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Summary 
The regulation of antigen processing and presenta-
tion to MHC c1ass I-restricted cytolytic T Iymphocytes 
was studled In cells Infected wlth murine cytomegalo-
virus. Recognitlon by cytolytlc T Iymphocytes 01 the 
phosphoprotein pp89, the Immunodomlnant viral anti-
gen expressed in the Immediate-early phase of infec-
tion, was selectively prevented during the subsequent 
expression of viral early genes. The surface expres-
sion 01 MHC class I glycoprotelns and their capaelty to 
present externally added pp89-derlved antigenie pep-
tides were not affected. Because recognition of sev-
eral other antigens oeeurred during the early phase, 
a general fallure In processlng and presentation was 
exeluded. Sinee neither rate 0' synthesls, amount, 
stabllity, nor nuclear transport 0' pp89 was modi'led, 
the failure In reeognition Indleates a selectlve inlerter-
enee wllh pp89 antigen processlng and presentation. 
Introducllon 
Recognition of antigens by T Iymphocytes requires their 
presentation by glycoproteins encoded in the major 
histocompatibility complex (MHC), a phenomenon re-
terred to as MHC restrlction (Schwartz, 1985). It Is as-
sumed that, after synthesis In infected cells, viral protein 
antigens have to be processed to yleld peptides that, after 
binding to the MHC-encoded glycoproteins expressed in 
those cells. are presented at the cell surface to the T cell 
receptor. Processing is a poorly understood event that ap-
pears to involve limited proteolytic degradation (Shimon-
kevitz et al.. 1983; Townsend et al.. 1985). Antigens 
presented by MHC class 11 molecules are processed in 
10w-pH endosomes, whereas antigens synthesized within 
the cell and presented by MHC class I molecules seem to 
be processed at a so far unknown. yet different, cytoplas-
mic site (Braciale et al., 1987; Germain, 1986, 1988). The 
location at which the physiological association of antigens 
with MHC cl ass I molecules takes place is not known ei-
ther, but it has been shown that externally added antigenic 
peptides can be presented at the cell surface (Townsend 
et al., 1986). 
Viruses can intertere with antigen presentation by af-
fecting the surface expression of cel! membrane proteins 
required for the recognition of infected ceUs by cytolytic T 
Iymphocytes (CTLs). For several viruses (Gooding, 1982; 
Bernards et al., 1983), including herpesviruses (Jennings 
et al. , 1985; Masucci et al. , 1987), defective antigen recog-
nition has been associated with decreased surface levels 
of MHC class I glycoproteins. For adenoviruses, there is 
evidence that the underlying mechanism is an active in-
terference with class I mRNA processing (Vaessen et al., 
1987) or with glycosylation (Burgert and Kvist. 1985). A 
correlation of these tindings with tumorigenicity and eva-
sion of adenoviruses and SV40 from the immune re-
sponse (Gooding, 1982; Bernards et al., 1983; Tanaka et 
al., 1985) is a matter of controversy (Haddada et al., 1988). 
For Epstein-Barr virus, evasion trom host-cellular immu-
nity has been suggested to result from the establishment 
of a latent infaction in cells that. owing to very low surface 
levels of accessory adhesion molecules, constitute poor 
targets tor antiviral CTLs (Gregory et al., 1988). As ex-
pected, and as actually shown 10r class I molecules (Yew-
deli et al., 1988), the reduction in the surface levels of cell 
membrane proteins required 10r antigen presentation and 
target cell recognition by CTLs indiscriminately prevents 
effieient reeognition of any antigen. 
Previous observations made with murine cytomegalovi-
rus (MCMV) infection suggest the existence of an interfer-
ence of viral gene products with antigen processing and 
presentation that is not mediated through a modulation in 
the expression of MHC class I molecules. In permissive 
cells, cytomegalovirus (CMV) gene expression is regu-
lated in a cascade fashion characteristic of herpesviruses 
(Stinski, 1983). Proteins expressed in the immediate-early 
(IE) phase of infection, such as the nonstructural regula. 
tory phosphoprotein pp89, wh ich is eneoded by MCMV 
gene iel (Keil et al., 1985, 1987; Koszinowski et al., 1986), 
are required tor the subsequent expression of early-phase 
genes, which, after onset of DNA replieation, are followed 
by late-phase genes. IE proteins also represent antigens 
recognized by the majority of antiviral CTLs (Reddehase 
and Koszinowski, 1984; Reddehase et al. , 1984; Koszi-
nowski et aI., 1987; Borysiewicz et al.. 1988). Vaccination 
of mice with the recombinant vaccinia virus MCMV-iel-
VAC, which expresses pp89 as the only MCMV gene prod-
uet (Volkmer et al. , 1987), sensitizes CD8+ T Iymphocytes 
that protect mice against lethai challenge with MCMV 
(Jonjic st al., 1988). The L d-restricted CTL clone IEl Iyses 
cells that selectively synthesize IE proteins (Reddehase et 
al.. 1986a) and is specific 10r a peptide of pp89 (Dei Val 
et al. , 1988; Reddehaseet al. , 1989). Clone IEl alsorecog-
nizes pp89 when it is synthesized again during the late 
phase of infaction, whereas, even though pp89 is present 
throughout the virus repUcation cycle, no recognition 
takes place du ring the early phase (Reddehase et al. , 
1986b). Because these experiments did not reveal any al-
teration in MHC elass I expression. an as yet unknown 
meehanism that prevents pp89 antigen presentation to 
CTLs must be postulated to operate during the early 
phase. 
In this artiele we describe that MCMV gene products in· 
terfere in a very selective way with the posttranslational 
steps of processing and presentation of pp89 for recogni. 
Cell 
306 
40 
'" ~ 
'" ;,;::
'~ 20 
c. 
!Il 
'$ 
o 
IE Early late 
( 1.5h p.i. 3-16h p.i. , 16h p.L 
a b c 
~ 
, 
IE 
CH/actO 
1\ 
10 D.6 10 0.6 10 0.6 10 0.610 
E: T ratio 
Early 
CH/-
e 
0.6 
Figure 1. Stage-Specifie Recognition 01 MCMV-Infected Cells by the 
pp89-Specilic CTL Clone IEl 
Recognition by clone IEl of 51Cr-labeled MCMV-infected MEF targets 
was tested in a cytolytic assay using graded numbers 01 elfector CTLs. 
Infaction eonditlons were as lollows: (a) after 1.5 hr 01 infection, ac-
tinomycin D (aet D) was added to prevent early gene expression and 
thus to achieve nonenhanced, selective IE protein synthesis; (b) cells 
were assayed al 3, 5, 8, 12, or 16 hr p.i. du ring the early phase 01 infec-
tion (summary 01 data); (c) cells were assayed at 24 hr p.1. du ring the 
late phase 01 inlection; (d) infection was perlormed In the presence 01 
cycloheximide (eH), which was replaced after 3 hr by act D to aehieve 
enhanced and selective IE protein synlhesis; (e) inlection was per-
formed in the presence of CH, which was removed alter 3 hr, resulting 
in enhanced IE gene expression concomitant with early gene expres-
sion. In (a), (d), and (e), the cytolytic assay slarted at 7 hr p.1. E:r ratio, 
ratio 01 IEl ellector cells to target ceUs. 
tion by MHC cl ass I-restrieted CTLs. Unlike the inhibitory 
mechanisms mentioned above, the surface levels of MHC 
class I mOlecules, as weil as their capacity to present both 
externally added and other endogenously synthesized 
viral antigens, remain unaffeeted. The data demonstrate 
that the three conditions regarded as essential and suffi-
cient tor target cell formation, namely, the presence of a 
sufficient amount of an antigenic protein, the funetional in-
tegrity of general processing mechanisms, and the pres-
ence of MHC molecules capable of presenting antigens, 
do not guarantee the recognition of that antigen by CTLs. 
These tindings thus reveal the existence of hitherto un-
known mechanisms regulating antigen processing and 
presentation. 
Results 
Transition to the Early Phase of MCMV Gene 
Expression Prevents Presentation of the IE 
Protein pp89 to CTL Clone IEl 
The kinetics of the expression of the MCMV IE protein 
pp89 in permissively infeeted mouse embryo fibroblasts 
(MEFs) have been determined previously (Keil et al., 1984, 
1985; Reddehase et al., 1986b). Gene lei encoding pp89 
(Keil et al. , 1987) is transcribed during the IE phase of viral 
gene expression, becomes silent during the early phase, 
and is transcribed again du ring the laie phase. The syn-
thesis of pp89 and the recognition of infected MEFs by the 
Ld-restrieted pp89-specific CTL clone IE1 also follow es-
sentially these kinetics (Figures la-lc; Reddehase et al., 
1986b). Specifically, infeeted cells are not recognized 
when virus gene expression proceeds into the early 
phase. This result was obtained when cells were arrested 
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Figura 2. Experimental Design 
(Top) Infaction 01 cells in the presenca of the protein synthesis inhibitor 
eH results in anhanced transcription of IE genes, including gene iet 
encoding pp89. Alter replacement of CH by the inhibitor of transcrip-
tion aet D, IE mRNA is translated, leading 10 enhanced and selective 
IE protein synthesis and 10 enhanced recognition 01 tE antigens by 
CTLs 4 hr laler (Reddehase et 81., 1984). 
(Bottom) 1I act D is not added immediately after removing CH, but at 
later time points. the synthesized IE proteins activate Ihe transcription 
of early (E) genes. The duration of E gene transcription is defined by 
the time al which act D is added. Translation of early mRNAs leads to 
the synthesis 01 E proteins. With this protocol, conditions of limited E 
gene expression after enhanced IE gene expression are achieved. 
in the early phase by performing the infeetion in the pres-
enca of phosphonoacetic acid (PAA) and tested 24 hr after 
infeclion (Reddehase et al., 1986b), and also when they 
were tested at different limes during the early phase (data 
10r 3, 5, 8,12, and 16 hr postinfeetion [p.i.] are jointly shown 
in Figure 1b). The faet that infeeted cells were no longer 
recognized by clone IEl after only 3 hr 01 permissive intee-
lion suggested that viral gene products expressed during 
the early phase negatively affeeted the presentation of 
pp89. 
Because the rate of pp89 synthesis is low in the physio-
logieallE phase, infection was per10rmed in the presence 
of cycloheximide (CH) to prevent translation, which results 
in an accumulation of IE transcripts. Enhancad and selec-
tive synthesis of IE proteins, the most abundant of which 
is pp89, is then accomplished by replacing CH by ac-
tinomycin D (aet D), which causes release from the trans-
lation block while preventing the transcription of early 
genes (see experimental design in Figure 2, top; Redde-
hase et al., 1986b). Under these conditions the synthesis 
01 pp89 continues for at least 8 hr without detectable de-
cline (Keil et 81.,1985), and the recognition of the cells by 
clone IEl is markedly increased (Figure 1d; Reddehase et 
81., 1984). 11, however, Ihe transition to early gene expres-
sion is not blocked by aet D after the removal of CH, the 
synthesis of pp89 from the accumulated IE transcripts 
declines with time (Keil et al., 1985) and the calls no longer 
constitute targets 10r clone IEl (Figure le). These results 
demonstrate the following: first, transition to the early 
phase, wh ich shuts off IE translation, also prevents the ex-
pression of the antigenie determinant of pp89 defined by 
clone IE1; second, this prevention is posttranscriptional; 
and third, It cannot be overcome by enhancing the tran-
scription of IE genes. 
Since pp89 can be deteeted with specific antibodies 
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Figure 3. Transition to the MCMV Early Phase Prevents Presentation 
01 pp89 to CTL Clone IE1 
Reeognition 01 pp89 wes tested in a cytolytie essay using the pp89-
specilic CTL clone IE1 (a and b) or MCMV-specific polyclonal CTLs (c) 
es effector cells. The target cells were prepared es follows: (a) MEFs 
were infeeted wilh MCMV in Ihe presence of CH for 3 hr. After removal 
01 CH, aet D was added eilher immedialely (.),20 min (.), or 45 min 
(A) later, as explained in Figure 2. Uninfected inhibitor-trealed cells 
ware used es a control (0). (b) Uie1-L d Iransfeclants, expressing pp89 
constitutively, were treated for 3 hr with CH. After removal of CH, aet 
D was added immediately (.) or after 45 min (A). Controls included 
Uie1-Ld cells not incubated with metabolie inhibitors (.) and ULd 
cells that do nol contain viral genes (x). (c) MEFs ware infected with 
MCMV-ie/-VAC in the presence of CH. Following removal of CH 3 hr 
later, aet D was added immediately (.) or after 45 min (A). As a con-
trol. cells infected with wild-type vaccinia virus and treated with the 
metabolie inhibitors were used (0). 'n all cases, the cytolytic assay 
started 7 hr afler addition 01 CH to target cells. Mean values of specific 
lysis are normalized for the maximum lysis obtained within each group 
(40% lor [al, 30% for [bI, and 24% for [cl). 
throughout the early phase, the data were thus far consis-
tent with the interpretation that recognition of the antigen 
by clone IE1 correlated with the synthesis of pp89 rather 
than with its presence (Reddehase et al., 1986b). The 
early phase lasts about 16 hr, du ring which transcription 
from the entire 235 kb genome, involving a high number 
of genes, is deteeted (Keil et a1., 1984). None of these 
genes is defined as yet. Viral funetions that cause the 
shutoff of pp89 synthesis and those that prevent the pre-
sentation of the IEl determinant may be speci1ied by the 
same gene or by different genes. In addition to early gene 
1unetions, an autoregulatory role of pp89 in antigen pre-
sentation has to be considered. 
To disseet these events, the experimental regimen ex-
plained in Figure 2 (bottom) was employed: by adding act 
D not immediately after removal of CH but at defined time 
points later, a variable period permissive for early gene 
transcription was set. With this approach it was deter-
mined that an interval of 20 min of early gene transciption 
was sutficient to diminish the presentation of the pp89 an-
tigen, and that an interval of 45 min completely interfered 
with it (Figure 3a). It has been demonstrated that pp89 can 
aetivate the transcription of cellular genes such as c..fos 
(Schickedanz et al., 1988). During the interval permissive 
tor early gene transcription, the pp89 synthesized in the 
absence of aet D could aetivate the transcription not only 
of viral early genes but also of cellular genes. Therefore, 
the possibility had to be considered that the inhibitory ef-
feet on pp89 antigen presentation was caused by cellular 
proteins induced by pp89. The same schedule of treat-
ment with the metabolic inhibitors of the trans1ectant cell 
line Uiel-L d, which expresses pp89 constitutively, as weil 
as of MEFs infected with the recombinant virus MCMV-ie/-
VAC, which expresses pp89 only upon infection, and both 
of which lack MCMV early genes, did not prevent or re-
duce lysis by CTLs (Figures 3b and 3c). These controls 
thus excluded the possibility that cellular proteins in-
duced by pp89 itsel1 or by related proteins translated from 
splicing derivatives in transcription unit ial (Koszinowski et 
al.. 1987) were responsible for the failure in pp89 antigen 
expression. In conclusion, the 1unetion that interferes with 
processing and presentation of the pp89 antigen is based 
on viral genes expressed in the first 45 min after transition 
to the early phase. 
Inhibition of pp89 Antigen Preaentatlon and 
of pp89 Synthesls Are Separate Events 
pp89 is not a struetural component of the virus particle; 
therefore, its synthesis in infected cells is required for rec-
ognition by pp89-specific CTLs. It was an open question 
whether the genes expressed during the first 45 min of the 
early phase, which abrogate pp89 antigen presentation, 
also caused the shutoff 01 pp89 synthesis or whether this 
effect was specified by genes expressed at later times 
during the prolonged early phase. To this end, protein syn-
thesis after periods of 20 and 45 min of early gene tran-
scription was analyzed by pulse-Iabeling and immunopre-
cipitation al 5, 7, and 9 hr p.L, Le., after 2,4, and 6 hr of 
translation. No difference was found at any time tested in 
the rate of synthesis of pp89 between cells expressing 
only JE genes (Figura 4A, Jane b) and those that also ex-
press early genes (Ianes c and d). Shown are only the data 
for 9 hr p.i., the time point that coincides with the end of 
the cytolytic assay. Posttranslational conversion 01 pp89 to 
pp76, which is mediated by cellular proteases (Keil et al., 
1985), was not altered either. The only difference detected 
after immunoprecipitation between cells Iysed by CTL 
clone IEl (Iane b) and those not recognized was the addi-
tional presence of early proteins (marked with E in Figure 
4A, lanes c and d). These results indicated that the genes 
that negatively affeet pp89 synthesis are not transcribed 
during the first 45 min of the early phase. It is worth noting 
that in spite of a significantly lower rate of pp89 synthesis 
in Uiel-L d transfectants (Iane e), these cells are efti-
ciently recognized by CTLs. The experimental dissection 
of the interference with pp89 antigen presentation and the 
down-regulation of pp89 synthesis proved that these are 
separate events operating at different times du ring the 
early phase. In addition, it was concluded from these data 
that the inhibitory efteet on pp89 antigen presentation 
operates posttranslationally. 
Expression of the First MCMV Early Genes Does 
Not Affect Amount, Stabillty, or Nuclear 
Transport of pp89 
Deficient presentation to CTLs of stable influenza virus 
proteins expressed in recombinant vaccinia virus-in-
fected cells has been shown recently to be overcome by 
construeting modified proteins with a reduced half-life 
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Figure 4. Expression of the First MCMV Early Genes Does Not Affect 
the Rate of pp89 Synthesis, the Posttranslational Conversion to pp76, 
or the Amount of pp89 
(A) The rate of synthesis of pp89 was measured by metabolie labeling 
of intected eells with (35S1methionine tor 20 min starting at 9 hr p.i. , 
followed by immunopreeipitation of eeillysates with anti-MCMV serum 
and polyacrylamide gel eleetrophoresis. Positions of the IE proteins 
pp89 and pp76 and 01 early proteins (E) are indicated. Lane a, unin-
fected MEFs. Lane b, MEFs inleeted with MCMV under enhaneed and 
selective IE eonditions (CH and aet 0 treatment). Lane e, MEFs that 
were inlected in the presenee of CH were ineubated lor 20 min in the 
absence 01 metabolie inhibitors belore aet 0 was added. Lane d, same 
as lane e but with a 45 min ineubation without inhibitors. Lane e, Uie1-
L d transleetants. 
(8) Amount of pp89 detected by Western blot of the cell Iysates de-
seribed in (A), lanes a-e, using the same antiserum as in (A). 
(Townsend et al. , 1988). This further strengthened the 
idea that processing of an antigen involves proteolytic 
degradation (Townsend et al., 1985, 1986). Following this 
reasoning, an increased stability of pp89 during the early 
phase could offer an explanation for the observed lack of 
recognition by CTLs. On the other hand, a different cleav-
age pattern of pp89 during the early phase might lead to 
the destruction of the epitope recognized by CTLs, and 
this would also result in a failure of antigen presentation. 
Therefore, the stability of pp89 during the IE and early 
phases was compared. 
As a first step, the amount of pp89 synthesized after re-
lease from the CH block and present in infected cells at 
5, 7, and 9 hr p.i. was measured by Western blot analysis 
in ceUs expressing only IE proteins and in cells also ex-
pressing early proteins. As shown in Figure 4B for 9 hr p.i., 
the amount of IE proteins was the same regardless of 
whether early genes were expressed (compare lane b with 
lanes c and d) and was clearly higher in infected (Ianes 
b-d) than in transfected cells (Iane e). As a second step, 
the stability of pp89 under IE and early conditions was 
measured by pulse-Iabeling with psSlmethionine at 3 hr 
p.i. followed by aperiod of chase in the absence of radio-
active precursor (Figure 5). With the aim of identifying the 
relevant protein fragments containing the IEl epitope, an 
antiserum raised against the 19 amino acid peptide of 
pp89 that contains this epitope (Dei Val et al., 1988) was 
used for immunoprecipitation. Even though efficiently 
presented to CTLs, pp89 synthesized in the IE phase 
represents a very stable protein, since most of the labeled 
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Figure 5. Stability and Nuelear Transport 01 pp89 Are Not Affeeted by 
MCMV Early Gene Expression 
MEFs were inleeted in the presenee of CH . After removal of CH at 3 
hr p.i., aet 0 was added eilher immediately (1) or after 45 min (2). Unin-
lectad eells trealad as in (1) ware used as a control (3). Cells were la-
beled lor 30 min wilh (35S1methionine immediately alter CH removal 
and then washed with an exeess of unla~eled methionine. Whole-cell 
Iysates (L) or cytoplasmie (C) and nuelear (N) Iractions were prepared 
immediately (Ianes a) and 3, 6, and 12 hr later (Ianes b, e, and d, respee-
tively). Immunopreeipitation was performed with a rabbit antiserum 
against peptide P(161-179), whieh eonlains the epitope reeognized by 
CTL clone IE1 in pp89. Sampies were analyzed by po/yaerylamide gel 
electrophoresis. Positions 01 pp89 and pp76 and indieated. 
pp89 was still detectable in the ceUlysates even after 12 
hr of chase (Figure 5, 1L, lanes a-d). The same stability 
was observed for pp89 when transcription was allowed for 
45 min (Figure 5, 2L, lanes a-d). Low amounts of proteins 
smaUer than pp89 that contained the IE1 epitope were de-
tected. These might represent either degradation prod-
ucts or proteins related to pp89 and arising by differential 
splicing from transcription unit ie1, which encodes pp89 
(Keil et al. , 1984, 1985). The protein pattern was the same 
under IE or early conditions, and was also identical with 
the one detected when, instead of the epitope-specific an-
tiserum, antiserum directed against the whole protein was 
used (data not shown), thus giving no indication of a selec-
tive destruction of the IE1 epitope. However, relevant frag-
ments of small size or very low abundance may have 
passed undetected. The same results were obtained 
when radioactive labeling was performed at 6 hr p.i. (data 
not shown). Altogether, these findings demonstrated that 
MCMV early gene expression was not associated with an 
alte red stability of pp89. 
After synthesis, pp89 migrates into the nucleus, where 
it activates transcription (Koszinowski et al., 1986). From 
a deletion mutant of pp89 that lacks the nuclear transport 
signal and is therefore confined to the cytoplasm, it is 
known that migration of pp89 into the nucleus is not re-
quired for recognition by CTLs (H. Volkmer and M. O. v., 
unpublished data). This finding is in accordance with the 
widely accepted idea (Germain, 1988) that processing of 
endogenously synthesized antigens takes place in a cyto-
plasmic compartment. On the other hand, enhanced 
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Recognition of pp89 was lested in a cytolytic 
assay using as elfector cells the CTL clone lEI 
(effector 10 target cell ratlos trom 30:1 10 0.5:1) 
(e) or pp89-specific polyctonal CTLs (effector 
10 target cell ratios from 500:1 10 8:1) (Al. For 
the preparalion of target cells, MEFs were in-
fected wilh MCMV in the presence 01 CH, 
which was removed after 3 hr. Act 0 was then 
added either immedialely (a) or after 15 (b), 25 
{cl, or 60 (d) min, as explained in Figura 2. The 
assay was pertormed al 7 hr p.i. Uninfected 
cells treated as in (a) were used tor control (e). 
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transport of pp89 into the nucleus during the early phase 
might result in a withdrawal of pp89 from cytoplasmic 
antigen-processing pathways, The rate of nuclear trans-
port of pp89 was therefore measured by tracing the la-
beled protein in the nuclear and cytoplasmic tractions of 
infected cells. With increasing periods of chase, the 
amount of labeled pp89 gradually decreased in the 
cytoplasm and was localized to the nuclear traction (Fig-
ure 5, C and N). No influence of early gene expression on 
the rate of nuclear transport could be detected (Figure 5, 
compare 1C and 1N with 2C and 2N), thus excluding an 
enhanced nuclear trapping of pp89 as an explanation tor 
the failure in pp89 antigen presentation during the early 
phase. 
In summary, neither a general enhancement of pp89 
stability, nor a detectable selective loss of the epitope, nor 
a different nuclear/cytoplasmic compartmentalization of 
the protein can account for the lack of pp89 antigen pre-
sentation to CTLs in the early phase. 
The Fate of the IE1 Epltope Reflects the 
Recognltlon of pp89 by BALBIc Polyclonal CTLs 
The data presented so far showed that the particular epi-
tope of pp89 defined by clone IE1 was no longer detect-
able when viral gene expression proceeded into the early 
phase. To study whether the fate of this epitope was repre-
sentative of the recognition of all pp89 epitopes, pp89 pre-
sentation to BALBIc pp89-specific polyclonal CTLs was 
analyzed. By using MCMV-ie/-VAC for in vivo sensitization, 
pp89-specific polyclonal CTLs were generated that recog-
nized cells arrested in the IE phase of MCMV infection 
(Figure 6a). Transition into the early phase prevented rec-
ognition of pp89 by these polyclonal CTLs with kinetics 
indistinguishable from those observed for clone IEl 
(Figures 6b-6d). In addition, it was found that pp89-
specific polyclonal CTLs did not Iyse infected fibroblasts 
of the mutant strain BALB/c-H-2dm2, in wh ich the L d gene 
is deleted (Table 1 B). These results demonstrated that rec-
ognition of pp89 by BALB/c polyclonal CTLs was entirely 
restricted through Ld, the same class I moleeule that 
serves as the antigen-presenting molecute for clone tEl. 
In conclusion, the epitope recognized by clone lEi truly 
reflected the recognition pattern of pp89 by polyclonal 
BALB/c CTLs. 
Surface Expression and Functional Integrity of the 
MHC Class I Molecule L d during the Early Phase 
For recognition by CTLs of viral antigens synthesized in 
an infected cell, antigenic peptides have to be presented 
by MHC-encoded class I glycoproteins. Interference with 
the cell surface expression of class I molecules can dimin-
ish or even abolish recognition by CTLs. Cytofluorometric 
determination of the surface expression of the MHC class 
I molecules Kd, Dd, and L d revealed no differences be-
tween cells that selectively synthesized JE proteins (Fig-
ure 7A, top panel), celts with restricted expression of earty 
genes (center panel), and uninfected cells (bottom panel). 
When L d served as a target antigen in a cytolytic assay 
using the Ld_Specific CTL clone B6aLd, no differences in 
target cell susceptibility to lysis were seen either (Figure 
7B). It was thus concluded that inhibition of pp89 presen-
tation was not associated with alterations in the surtace 
expression of class I molecules. 
Vet, these results did not exclude an alteration in the 
function of the class I molecules to serve as antigen-
presenting molecules, It has been proposed that incu-
bation of target cells with peptides circumvents the in-
tracellular steps of processing, since it leads to target cell 
recognition by CTLs (Townsend et al., 1986). The synthetic 
nonapeptide VPHFMPTNL (one-Ietter code), which is 
deduced from the pp89 sequence, represents the optimal 
antigenie peptide tor CTL clone IE1 (Reddehase et al., 
1989). Incubation with this nonapeptide of cells that ex-
pressed MCMV early genes and did not present en-
dogenously synthesized pp89 reveated that these cells 
ware still able to present the externally added nonapep-
tide (Figure 7C, center panel). Identical resutts with the 
suboptimal heptapeptide PHFMPTN confirmed this con-
clusion (data not shown). Therefore, the block in pp89 pre-
sentation was caused neither by an alteration in the cell 
surface expression of L d nor by a defect in its function to 
present antigenic peptides. 
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Table 1. Differential Presentation of MCMV Antigens to CTLs du ring the Early Phase of the Viral Replication Cycle 
Genes Expressed CTLs* 
in Target Cells Clone Polyclonal Clone Clone Polyclonal 
MHC' MCMvt IE1 Anti-pp89 E1 E2 Anti-MCMV 
A. KdDdLd IE phase 4O§ 59 0 0 48 
KdDdLd IE + E phase 1 7 60H 40 74 
KdDdLd 0 0 0 0 3 
B. KdDd IE phase 0 4 0 20 
KODd IE + E phase 0 0 4 0 38 
KdDd 0 0 0 0 5 
C. Ld EeoRI F 0 ND 29 0 ND 
Ld 0 ND 7 0 ND 
D. KbDb IE phase 0 21 0 ND 25 
KbDb IE + E phase 0 9 0 ND :g 
KbDb 0 8 0 ND 8 
• Target eells: MEFs trom BALB/e mice (A), BALB/c-H-2dm2 mice (B), or C57BLl6 mice (D). LlLd cells ware transtacted with fragment EcoRI F 
trom MCMV DNA (C). 
tinfeetion eonditions: IE phase, enhanced and seleetive IE expression, as described in Figure 2, top. IE + E phase, infection performed in the 
presence of PM to prevent late-phase gene expression. 
* CTL clones were derived from BALBte (H-2d) mice. POlyclonal CTLs were obtained either trom BALBte mice (for A and B) or from C57BLl6 (H-2b) 
mice (for D). 
§ Percenlages of specific lysis obtained at effector 10 target cell ratios of 20:1 (for CTL clones) or 100:1 (for polyclonal CTLs). 
'I Underlined are results that revealed the presentation of viral antigens other than pp89 during the early phase of the MCMV replication cycle. 
ND, nol done. 
Selectlvity of the Negative Regulation of pp89 
Antigen Processlng and Presentation 
From all these findings It can be eoneluded that the Inter-
ferenee with pp89 antigen expression involved the poorly 
defined intraeellular steps of the antigen-proeessing and 
-presentation pathways. To study whether this negative 
regulation is selective tor pp89 or eoneerns antigen pre-
sentation in general, the effect on the presentation of other 
MCMV antigens expressed concomitantly with pp89 was 
analyzed (Table 1) . To this end, CTLs derived from in-
fected mice were cloned and screened tor recognition of 
cells infected with MCMV in the presence of PAA. Viral 
gene expression in such cells is restricted to IE and early 
genes, and, although they are not recognized by CTL 
clone IE1, they constitute targets for polyclonal MCMV-
specific CTLs (Reddehase et al., 1984). With this ap-
proach, two new CTL clones were established, E1 and E2, 
both of which recognized MCMV early antigens since they 
were able to Iyse cells infected in the presence of PAA but 
did not recognize cells infected under IE conditions (Table 
1A). Antigen recognition by both clones was restricted 
through Ld, since no lysis of infected BALB/c-H-2<'m2 cells, 
which lack L d, was detected (Table 1 B). CTL clone El, but 
not clone E2, recognized L/Ld cells transfected with the 
EcoRI F fragment of MCMV ONA (Ebeling et al., 1983; B. 
Bühler et al. , unpublished data) , which indicated that 
these two CTL clones have different antigen specificities 
(Table 1C). Lysis of infected cells by clones E1 and E2 was 
not higher during the late phase than du ring the early 
phase (not shown). The objection that presentation of E1 
and E2 antigens might also have been inhibited during the 
early phase, although to a lower extent than pp89, can 
thus be refuted. Presentation of these two antigens could 
account for the recognition of early-phase infected cells by 
polyclonal MCMV-specific CTLs (Table 1A); however, addi-
tional viral antigens must be presented during the early 
phase by the Kd or Od glycoproteins, beC8use BALBlc-H-
2dm2 cells infected in the presence of PAA were also rec-
ognized by these polyclonal CTLs (Table 1B). It was there-
fore concluded that, even though presentation of pp89 to 
BALBlc CTLs was prevented du ring the early phase. pre-
sentation of at least three other viral antigens, two of them 
L d restricted, as is pp89 itself, was nevertheless very effi-
cient. 
When recognition of MCMV-infected cells by C57BU6 
(H-2b) pp89-specific polyclonal CTLs was analyzed, it 
was found that, as was the case in the H-2d haplotype, 
presentation of pp89 by H-2b cl ass I molecules did occur 
during the IE phase but was prevented during the early 
phase (Table 10). Again, the testing of MCMV-specific 
polyclonal CTLs revealed further viral antigens presented 
during the early phase by H-2b class I molecules (Table 
10). 
COllectively, the results summarized in Table 1 demon-
strate that the inhibitory effect on pp89 antigen presenta-
tion is highly selective, because at least two viral early an-
tigens presented by L d, at least one presented by Kd or 
Od, and at least one presented by Kb or Ob were not sub-
iect to this inhibition. A general block aftecting processing 
and presentation of all nascent viral antigens in the early 
phase of MCMV replication was thus excluded. 
Inhibition of pp89 Presentation Cannot Be 
Explalned by Antigen Competition 
for the Presenting Moleeule L d 
Competition between different antigens presented by the 
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Figure 7. Expression of MCMV Early Genes Does Not Modify the Sur-
face Levels or Ihe Peptide Presentation Function of MHC Cisss I Mole-
eules 
MEFs were in1ected under enhanced and selective IE conditions (top 
panels) or under condltions in whieh early transcription was limited to 
2 hr (center panels) as explained in Figure 2. Uninfected MEFs treated 
with the metabolie inhibitors are shown as controls in the bottom 
panels. 
(A) Surfaee levels of H-2<1 class I molacules were measured by ftow . 
cytofluorometryat 7 hr after in1ection or mock infection on cells labeled 
with mouse monoclonal antibodies specific for Ld, Kd, and 00, as indi-
cated, foIlowed by labaling with fluoresceinated anti-mouse antibody. 
The dotted lines represenl background labeling obtained with the 
fluoresceinated anti-mouse antibody alone. 
(B) Recognilion of surface ld molacules on 5tCr-labeled target cells 
by the L d-apeclfic CTL clone B6aL d. 
(C) Presentalion of the pp89-derived synlhetic peptide YPHFMPTNL 
after a 1 hr incubation of target cella with 100 pM peptide (.), mea-
au red in a cytolytic assay using CTL clone IE1 as effector celis. Control 
cells not incubated with peptide (0) were also tested. 
same MHC class I molecule and recognized by CTLs can 
be demonstrated with synthetic peptides (Maryanski et 
al. , 1987). In particular, it has been recently shown that 
peptides derived from the tum- antigen P91A (Oe Plaen 
et al., 1988) and pp89-derived peptides, the only two anti-
genic sequences presented by the L d glycoprotein that 
have been charaeterized so tar, can mutually compete for 
L d (Lurquin et 81., 1989). Ouring the early phase of infec-
tion, when the IE protein pp89 is not presented by Ld, 
other antigens are recognized by the Ld-restricted CTL 
clones E1 and E2. Competition tor the L d molecule e1-
feeted by these early antigens could possibly prevent pre-
sentation of pp89 du ring the early phase. 
To test this hypothesis, the kinetics of pp89 and E1 anti-
gen expression were analyzed during the transition trom 
the IE to the early phase. The duration of early gene tran-
scription was limited by the addition of aet 0 at different 
times after removal of CH, in order to detect the time at 
which the earty gene encoding the El antigen is ex-
1 2 3 4 
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Figure 8. Presentalion by L d of the E1 Epitope and 01 pp89 Can Oe-
cur Simultaneously 
(A) Kinetics of antigen expression in the trensition lrom the IE to Ihe 
early phase. MEFs were infected with MCMV in the presenee of CH, 
which was washed out 3 Ilr later. Tlle time points at which act 0 was 
added define Ihe duration of early gene transcription. In a11 oasea, 8 
hr for protein synthesis, antigen processing, end antigen presentation 
was allowed bafore the target cells were assayed for recognltlon by 
pp89-specific L d-restricted polyclonal CTLs at an effector 10 target cell 
ratio (E:T ratio) of 25:1 (.), and by the early-specific L d-restricted CTL 
clone E1 at an E:T ratio of 5:1 (0). 
(B) Antigen expression in the late phase. MEFs were infected wlth 
MCMV at a multiplicity 01 2 in the absence of metabolie inhibitors, and 
t&Sled at 20 hr p.i. with pp89-specific poIyclonai CTls (.) and wilh CTL 
clone E1 (0). 
pressed. The results shown in Figure 8A indicate that 2-4 
hr of early gene transcription was required eventually to 
obtain an amount of El antigen sufficient for deteetion by 
CTL clone E1. This period 01 early gene transcription was 
longer than the period required to prevent pp89 antigen 
presentation, thus suggesting that E1 peptide competition 
for L d was unlikely. It could be argued, however, that the 
amount of El peptide required for competition with pp89 
is lower than the amount required for target recognition by 
CTL clone E1. This possibility was excluded by the finding 
that simultaneous presentation of pp89 and E1 took pi ace 
in the late phase of the virus replication cycle (Figure 8B). 
Recognition of infeeted cells by CTL clone E2 also oe-
curred during the late phase (data not shown). Thus, suffi-
cient amounts of E1 and E2 peptides were present in the 
late phase to produce a target; nevertheless, they did not 
exert an inhibitory effect on the presentation of pp89-
derived peptides. 
In summary, the seleetive prevention of pp89 antigen 
presentation that occurs during the early phase of the 
MCMV replication cycle cannot be explained by competi-
tion for binding to the L d molecule exerted by the en-
dogenously synthesized viral antigens E1 and E2. 
Discusslon 
In response to infection with MCMV, BALBJc mice gener-
ate proteetive T Iymphocytes of the C08+ subset. These 
T Iymphocytes predominantly recognize antigens synthe-
sized during the IE phase of the viral replication cycle. 
Vaccination with the recombinant vaccinia virus MCMV-
lel-V AC, encoding the major IE protein pp89, renders mice 
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rasistant to lethai challenge with MCMV. By using both 
polyclonal and cloned pp89-speeific MHC class I (Ld)-re-
stricted CTL lines, regulation of the presentation of pp89 
was examined throughout the virus replication cycle. We 
present evidence 10r the following: first, similar to MCMV 
gene expression, which is temporally regulated in three 
phases-namely, IE, early, and late-pracessing and pre-
sentation of pp89 for recognition by CTLs is under strict 
contral, displaying the same kinetics; second, arrest of the 
viral replication cascade in the IE phase, as weil as selec-
tive expression of the isolated gene iel encoding pp89, 
provide efficient antigen presentation; third, release trom 
the arrest followed by expression of the first viral early 
genes completely prevents pp89 antigen presentation; 
fourth, the late phase of gene expression is associated 
with reinitiation of pp89 synthesis and release from the in-
terference with antigen presentation; fifth, the interfer-
ence with pp89 antigen presentation occurs posttransla-
tionally but does not involve alterations in protein amount, 
stability, or nuclear compartmentalization; sixth, the sur-
face expression and antigen-presenting function of the 
MHC class I molecule Ld are not affected; and seventh, 
the intervention with pp89 antigen processing and pre-
sentation is highly selective in that it does not apply to 
other MCMV antigens synthesized concomitantly with 
pp89 in the infected cells and presented by several differ-
ent class I molecules, including Ld. 
This report gives a clear example for a highly selective, 
temporally regulated, and reversible prevention of viral an-
tigen presentation to elass I-restricted T Iymphocytes. 
The results indicate that the interference takes place at an 
intracellular stage of pp89 antigen processing after trans-
lation and before the presentation of antigenic peptides at 
the cell surface. 
Because of its selectivity, the inhibition of pp89 presen-
tation is unlike other reported cases of interference with 
antigen recognition by CTLs, all of which could be ex-
plained by a general decrease in the surface levels of ce 1-
lular presenting or adhesion moleeules (Gooding, 1982; 
Bernards et al. , 1983; Jennings et al., 1985; Masucci et al. , 
1987; Gregory et al.. 1988) that indiscriminately affects the 
presentation of any antigen. 
An observation more closely related to the data pre-
sented in this article has been made in recombinant vac-
cinia virus-infected cells. in which presentation of influen-
za virus antigens to CTLs was influenced by the phase of 
vaccinia virus gene expression (Coupar et al. , 1986). Dur-
Ing the late phase of the virus replication cycle, and to 
some extent also during the early phase, partial or total in-
hibition of presentation of several influenza virus epitopes 
was observed (Townsend et al., 1988). Vaccinia virus-in-
duced shutof1 of cellular functions was discussed as a 
possible mechanism of the inhibition of antigen presenta-
tion. Beeause restoration of antigen recognition could be 
achieved by reducing the stability of influenza proteins, it 
was proposed, as an alternative explanation, that putative 
protease inhibitors encoded by vaccinia virus might be 
responsible for the observed inhibition of antigen pro-
cessing. 
Besides the replication-phase association, the inhibi-
tory effect observed here for MCMV has little in common 
with the inhibitory effect described for vaccinia virus, and 
the mechanisms postulated there may not apply. First, 
MCMV does not induce a strong host shutoff, in particular 
not at the beginning 01 the early phase. Second, in com-
parison with the IE phase, when pp89 presentation was 
optimal, no alterations in pp89 stability were observed 
during the early phase, when presentation was blocked. 
For teehnicaJ reasons, an MCMV recombinant expressing 
an unstable pp89 has not been constructed to date. If, as 
the data presented by Townsend et al. (1988) convincingly 
suggest, the rate of protein degradation governs antigen 
processing, then an accelerated catabolism of pp89 
resulting in its processing before the inhibitory function 
has had time to operate would restore antigen presenta-
tion in cells infected with such an MCMV recombinant. 
This, however, would not explain the mechanism 01 inter-
ference with pp89 presentation. Third, the highly selective 
nature of the inhibition of pp89 antigen presentation is not 
compatible with the more general eftect of protease inhibi-
tors. Recently the human CMV, a virus closely related to 
MCMV, has been completely sequenced. Comparison of 
open reading frames coding 10r polypeptides of 300 
amino acids and larger with available data bases has, un-
like the example of vaccinia virus (Kotwal and Moss, 1989), 
revealed no detectable homology to known serine pro-
tease inhibitors (B. G. BarrelI, personal communication). 
In summary, as opposed to the vaccinia virus system, a 
meehanism ot inhibition that selectively aftects pp89 must 
be proposed for MCMV. 
An alternative mechanism that we considered is compe-
tition at the peptide level tor binding to the Ld molecule. 
Related pp89-derived synthetic peptides, differing only in 
length and a11 containing the antigenic core sequence 
HFMPT, differ considerably in their antigenic potency, 
with the nonapeptide YPHFMPTNL having a very high af-
finity tor Ld (Reddehase et al., 1989). Since it is not 
known which ot these peptides are actually generated in 
infeeted cells, it is highly possible that peptides derived 
from the early antigens E1 and E2 have a higher affinity 
for L d. However, because simultaneous recognition of 
pp89, E1, and E2 was feasible in the late phase, peptide 
competition exerted by E1 or E2 is not a likely meehanism. 
It can be expeeted that, if pp89 were competed out by an 
unknown competitor stronger than E1 and E2, this com-
petitor should also compete with E1 and E2. From all this, 
it appears that the number of L d molecules available for 
binding of peptides is not the limiting factor tor pp89 pre-
sentation. Finally, the fact that the inhibitory effect oper-
ated also in the H-2b haplotype, in which the antigenic 
determinants of pp89 and of early antigens are most prob-
ably different trom those presented by Ld, also disfavors 
competition. 
In view of the evidence available, we hypothesize that 
inhibition of pp89 presentation is caused by a selective ef-
fect on pp89 exerted during the early phase by a viral pro-
tein or by a cellular factor induced by it. The selectivity of 
the effeet may relate to the regulatory function of pp89. As 
a mechanism, one could imagine complex formation with 
pp89 or an enzymatic activity exerted on pp89, either of 
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which could prevent correct processing or transport 10 the 
cell surface. Studies with mutated pp89 may help to iden-
tify possible target sequences for the proposed interac-
tions, and analysis of the genes transcribed during the 
first period of the early phase should contribute 10 the un-
derstanding of the underlying mechanism. 
An interesting impUcation of our results is the fact that 
abundant expression of a protein of proven antigenicity in 
cells that express all molecules essential for antigen pro-
cessing and presentation does not inevitably result in pre-
sentation of this antigen. It is worth considering that the 
presentation of certain cellular protein antigens may be 
subject to similar control mechanisms. Such regulatory 
mechanisms could add considerably to the complexity of 
self/nonself discrimination. 
Under the control of the immune system, CMV persists 
for life in the infected host in astate of latency that is as-
sociated with a block in viral gene expression, a character-
istic of herpesviruses. For human CMV there is evidence 
that IE genes, but not late genes, are expressed in latently 
infected cells (Rice et al. , 1984; Schrier et al., 1985). Since 
in human CMV the gene IE1 corresponding to gene iel of 
MCMV also codes for an immunodominant antigen for 
CTLs (Borysiewicz et al., 1988), it remains an unsolved 
question how latently infected cells expressing a protein 
of proven antigenicity can survive in the face of a specific 
CTL response. The kind of negative regulation of antigen 
presentation documented here for MCMV could provide 
the solution for this paradox. 
Experimental Pl'OOedures 
Mice 
BALBIc mice (H-2d haplotype), BALB/c-H-~m2 mutant mice lacking Ld 
(Hansen et al., 1977). and C57BLJ6 mice (H-2b haplotype) ware bred 
in our own colony under specific-pathogen-free conditions. 
Cells and Vlruses 
Third-passage MEFs were used for virus inlection. The LJL d line of L 
fibroblasts (H-2k haplotype). which is transfected with the gene for the 
MHC class I moleeule L d. and the LJie1-L d line, which is transfected in 
addition with MCMV transcription unit ie1. have been described previ-
ously (Koszinowski et aI., 1987). MCMV of the strain Smith (VA-194; 
American Type Culture Collection. Rockville, MD) was employed as 
tissue-culture-grown virus. The production of the recombinant vaccinia 
virus MCMWe/-VAC. enCQding pp89. has been reported before (Volk-
mer et aI., 1987). 
Cytolytlc Effector Cella 
Generation 01 MCMV-specifie and pp89-specilic polyclonal CTLs was 
achieved by in vitro restimulation with MCMV 01 spleen cells from mice 
that ware latently infected with MCMV and inlected with 1 x 10S PFU 
of MCMV-iel.llAC 3 weeks before, respectively (Dei Val et aI .• 1988). 
The L d-restricted pp89-specilic CTL clone IE1 (Reddehase et al.. 
19B6a, 1989) and the L d..specific CTL clone B6o.L d (Reddehase et al., 
1986b) have been eharacterized previously. The l d-restricted CTL 
clones E1 and E2. whieh are specific for MCMV early antigens, ware 
cloned by limiting dilution from MCMV-specific polyclonal CTL cul· 
tures. Clones El and E2 ware grown In medium contalning 100 U/ml 
recombinanl human interleukin 2 (Sandoz Forschungsinstitut, Vienna. 
Austria), and restimulated weekly with MCMV and stimulator cells as 
described for clone IE1 (Reddehase st al., 1986a). 
Target Cella and Cytolytlc Anaya 
For selectiVe and enhanced expression ollE genes, MEF ware infected 
with 0.5 PFU of MCMV per cell by centrifugation (800 x g, 30 min), 
which results in a multiplicity of infection 0110-20 (Reddehase et al., 
1984). Inlection was performed in the presence 01 CH (50 ",gImi). which 
was removed 3 hr later by washing with medium containing act 0 (5 
I1glml). limited early gene transcription alter the CH treatment was 
achieved by removal of CH using inhibitor-free medium and byadding 
act 0 to the final concentration of 5 I1g1ml after the intervals indicated. 
The same metabolie inhibitor treatment was performed on Uie1-L d 
eells. Inlection of MEF with MCMWe/-VAC was done as with MCMV ex-
cept that a multiplicily of 3 was used. 
Restriction 01 gene expression 10 the IE and early phases of the 
MCMV replication cycle was achieved by infecting MEF with MCMV 
in the presence 01 PAA (250 l1g1ml) 10 prevent viral ONA replication and 
late-phase gene expression. 
Target cells ware trypsinized and labeled for 90 min with Na251Cr04. 
and a standard 3 hr cytoIytic assay was performed with 1000 target 
cells and graded numbers of effector cells in 2-fold dilution steps. Oata 
represent Ihe mean percentage of specific lysis from three replicate 
cultures. For preparing !arge! cells with exogenously added peptides, 
cells ware incubated with peptides al a concenlration 01 100 11M for 1 
hr at 37"C after the 51Cr labeling, followed by removal 01 excess pep-
tide by washing the target eells before the addition of effector cells. 
Immunoprecipltation and Western Blot Analysis 
Experiments were performed essentially as described (Keil el al. , 
1985). In brief, the same number of Uie1-ld cells. uninlected MEF. 
and MEF infected with MCMV under the same conditions as used lor 
target cell preparalion ware labeled with [35S)methionine in methio-
nine-free medium for 20 min, starting al 5, 7. and 9 hr p.1. Ceillysates 
were immunoprecipitated with a murine antiserum 10 MCMV and ana-
Iyzed by 10% polyacrylamide gel electrophoresis and autoradiogra-
phy. Western blot analysis was performed wilh the same Iysates. 
which, after separation by electrophoresis. ware blotted onto a nitrocel-
lulose membrane and incubated with the same antiserum. 
Pulse-Labellng, Chase, and NuclearlCytoplasmlo Fractionation 
Uninfected MEFs and MEFs infected with MCMV In the presence of CH 
ware trypsinized at 3 hr p.i., that iso immedietely after CH removal. and 
labeled with [35Slmethionine for 30 min in medium devoid of unla-
beled methionine. Ac! 0 was added at the indicated times. After the 
labeting period, cells were washed twiee with medium containing a 
2QOO..foId excess of unlabeled methionine, followed by further incuba-
tion in medium containing the standard concentration of methIonine. 
At given time points, atiquots ware taken for the preparetlon of whole-
ceillysales and tor the seperation of nuclear and cytoplasmic fractions 
(Keil et al., 1985). This separation was achieved by resuspending the 
sedimented cells for 5 min in ice-cold buffer I (10 mM Trls-HCI (pH 8.51. 
0.14 M NaCl. 1.5 mM MgC12, 0.5% Nonidel P-40), foIlowed by centrifu-
gation (800 x g, 4"C. 5 min) Ihrough a cushion of 24% sucrose in 
bufler I. Lysates ware then prepared trom the cytoplasmic frection on 
top of the cushion and from the sedimented nuclei. lysates ware ana-
Iyzed by immunoprecipitation and gel electrophoresis. A rabbit antise-
rum raised agalnst the synthetic peptide p(161-179) of pp89 coupled 
10 bovine serum albumin as descrlbed (Dei Val et al., 1988) was used 
lor immunoprecipltation. 
Flow Cytofluorometry 
Uninfected MEFs and MCMV-infected MEFs ware trealed with CH and 
act 0 foIlowing the protocol for target cell preperatlon. They ware then 
incubated with the monoclonal antibodies 822-249 (Lemke et al.. 
1979),34.5.88, and 31.3.48 (Cachet et aI .• 1986), specific for Ld, [)d. 
and K". respectively, followed by fluorescein-conjugeted (F(ab'k frag-
ments of goal anti-moose IgG antibodies (Jackson Immunoresearch 
laboratories lne., West Grove. PA) and analyzed on a FACS IV as da-
scribed (Reddehase et at .• 19B6a). 
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